Home / Stocks / ENGN

ENGN insider trading

enGene Therapeutics Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$8.1M
Buys · last 90 days
1 · $10k
Most recent buy
2026-09-24

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-09-24Grossman William
Interim Chief Medical Officer
Bought5,102$1.97$10k
2024-11-01Forbion Growth Management B.V.
10% owner
Bought561,797$8.90$5.0M
2024-10-18Forbion Growth Management B.V.
10% owner
Bought470,633$6.40$3.0M
2024-10-01Cooper Ronald Harold Wilfred
Chief Executive Officer
Bought10,000$5.70$57k

Most active insider buyers

InsiderRoleBuysTotal bought
Forbion Growth Management B.V.10% owner2$8.0M
Cooper Ronald Harold WilfredChief Executive Officer1$57k
Grossman WilliamInterim Chief Medical Officer1$10k

See ENGN on the chart

Every insider buy and sell for ENGN plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.